Cargando…

Validity of three risk prediction models for dementia or cognitive impairment in Australia

BACKGROUND: no studies have compared the predictive validity of different dementia risk prediction models in Australia. OBJECTIVES: (i) to investigate the predictive validity of the Australian National University-Alzheimer’s Disease Risk Index (ANU-ADRI), LIfestyle for BRAin Health (LIBRA) Index and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geethadevi, Gopisankar M, Peel, Roseanne, Bell, J Simon, Cross, Amanda J, Hancock, Stephen, Ilomaki, Jenni, Tang, Titus, Attia, John, George, Johnson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804251/ https://www.ncbi.nlm.nih.gov/pubmed/36585910 http://dx.doi.org/10.1093/ageing/afac307

Ejemplares similares

Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?
por: Livori, Adam C., et al.
Publicado: (2023)

Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide study
por: Koponen, Marjaana, et al.
Publicado: (2022)

COVID‐19 restrictions and the incidence and prevalence of prescription opioid use in Australia – a nationwide study
por: Jung, Monica, et al.
Publicado: (2022)

Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study
por: Leung, Miriam T. Y., et al.
Publicado: (2023)

Correction to: Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study
por: Leung, Miriam T. Y., et al.
Publicado: (2023)

Shift from older‐ to newer‐generation antiseizure medications in people with acute ischemic stroke in Australia: A population‐based study
por: Kim, Stella Jung‐Hyun, et al.
Publicado: (2023)

Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment
por: Raghunandan, Rakhee, et al.
Publicado: (2023)

Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in Australia
por: Ofori-Asenso, Richard, et al.
Publicado: (2018)

Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia.
por: Nielsen, Suzanne, et al.
Publicado: (2023)

Zinc in Preventing the Progression of pre-Diabetes (ZIPPeD Study) – study protocol for a randomised placebo-controlled trial in Australia
por: Peel, Roseanne, et al.
Publicado: (2019)

Thyroid Antibodies, Autoimmunity and Cognitive Decline: Is There a Population-Based Link?
por: Napthali, Kate, et al.
Publicado: (2014)

Diagnosis of Dementia and Cognitive Impairment
por: Larner, Andrew J.
Publicado: (2019)

Participant-Centered Online Active Surveillance for Adverse Events Following Vaccination in a Large Clinical Trial: Feasibility and Usability Study
por: Munnoch, Sally-Anne, et al.
Publicado: (2019)

Optimising care for patients with cognitive impairment and dementia following hip fracture
por: Gill, Nigel, et al.
Publicado: (2017)

Cognitive Impairment in Strategic Infarct Dementia: A Report of Three Cases
por: Sanker, Vivek, et al.
Publicado: (2022)

Validation of multi-stage telephone-based identification of cognitive impairment and dementia
por: Crooks, Valerie C, et al.
Publicado: (2005)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study
por: Wood, Stephen, et al.
Publicado: (2021)

Validity of the Brief Assessment of Impaired Cognition case‐finding instrument for identification of dementia subgroups and staging of dementia
por: Jørgensen, Kasper, et al.
Publicado: (2022)

Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan
por: Takenoshita, Shintaro, et al.
Publicado: (2019)

Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model
por: Liu, Qiang, et al.
Publicado: (2022)

Serum Methylarginines and Spirometry-Measured Lung Function in Older Adults
por: McEvoy, Mark A., et al.
Publicado: (2013)

Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment
por: Moreland, Jamie, et al.
Publicado: (2018)

Cognitive impairment and dementia—an update
por: Massano, João
Publicado: (2012)

Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia
por: Kan, Kwai Ching, et al.
Publicado: (2019)

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
por: Wood, Stephen J, et al.
Publicado: (2022)

Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study
por: Sharma, Abhipree, et al.
Publicado: (2023)

Appropriateness of Surgical Antimicrobial Prophylaxis Practices in Australia
por: Ierano, Courtney, et al.
Publicado: (2019)

Validation of Brief Screening Tools to Identify Impaired Driving Among Older Adults in Australia
por: Anstey, Kaarin J., et al.
Publicado: (2020)

Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function
por: Reay, William R, et al.
Publicado: (2021)

A Computerized Cognitive Test Battery for Detection of Dementia and Mild Cognitive Impairment: Instrument Validation Study
por: Ye, Siao, et al.
Publicado: (2022)

Reliability and validity of a quick test of cognitive speed (AQT) in screening for mild cognitive impairment and dementia
por: Afshar, Pouya Farokhnezhad, et al.
Publicado: (2021)

Characterising the use of varenicline: an analysis of the Australian dispensing claims data
por: Gobarani, Rukshar K., et al.
Publicado: (2022)

Factors associated with antimicrobial choice for surgical prophylaxis in Australia
por: Ierano, Courtney, et al.
Publicado: (2020)

Age-Correction of Test Scores Reduces the Validity of Mild Cognitive Impairment in Predicting Progression to Dementia
por: Hessler, Johannes, et al.
Publicado: (2014)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Diagnosing dementia in the Arctic: translating tools and developing and validating an algorithm for assessment of impaired cognitive function in Greenland Inuit
por: Kleist, I., et al.
Publicado: (2022)

Diagnostic Accuracy, Effectiveness and Cost for Cognitive Impairment and Dementia Screening of Three Short Cognitive Tests Applicable to Illiterates
por: Carnero-Pardo, Cristóbal, et al.
Publicado: (2011)

Validation of a new mass screening tool for cognitive impairment: Cognitive Assessment for Dementia, iPad version
por: Onoda, Keiichi, et al.
Publicado: (2013)

Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients
por: Janssen, M. A. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ei9i4jfi3frqmtk97nuvk0t3iq